Literature DB >> 9010411

Rapid neurological deterioration in a patient with multiple sclerosis treated with systemic interleukin-2 and interferon-alpha 2b for metastatic renal cell carcinoma.

R P Kinkel, R A Rudick, R M Ransohoff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9010411      PMCID： PMC486706          DOI： 10.1136/jnnp.62.1.100

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  4 in total

1.  Reactivation of rheumatoid arthritis during continuous infusion of interleukin 2: evidence of lymphocytic control of rheumatoid disease.

Authors:  M Lavelle-Jones; A al-Hadrani; E M Spiers; F C Campbell; A Cuschieri
Journal:  BMJ       Date:  1990-07-14

2.  Interleukin 2 and psoriasis.

Authors:  R E Lee; A A Gaspari; M T Lotze; A E Chang; S A Rosenberg
Journal:  Arch Dermatol       Date:  1988-12

Review 3.  Multiple sclerosis: immune system molecule expression in the central nervous system.

Authors:  C S Raine
Journal:  J Neuropathol Exp Neurol       Date:  1994-07       Impact factor: 3.685

4.  Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions.

Authors:  A Windhagen; J Newcombe; F Dangond; C Strand; M N Woodroofe; M L Cuzner; D A Hafler
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307
  4 in total
  1 in total

1.  Dystonia in a patient with melanoma metastatic to the brain treated with high-dose interleukin-2, radiation therapy, and levetiracetam.

Authors:  Varun Sreenivasan; Arkadiusz Z Dudek
Journal:  Case Rep Oncol       Date:  2013-01-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.